Merck Manual

Please confirm that you are a health care professional

honeypot link

Torsades de Pointes Ventricular Tachycardia


L. Brent Mitchell

, MD, Libin Cardiovascular Institute of Alberta, University of Calgary

Reviewed/Revised Jan 2023
Topic Resources

Torsades de pointes ventricular tachycardia is a specific form of polymorphic ventricular tachycardia in patients with a long QT interval. It is characterized by rapid, irregular QRS complexes, which appear to be twisting around the electrocardiogram (ECG) baseline. This arrhythmia may cease spontaneously or degenerate into ventricular fibrillation. It causes significant hemodynamic compromise and often death. Diagnosis is by ECG. Treatment is with IV magnesium, measures to shorten the QT interval, and direct current defibrillation when ventricular fibrillation is precipitated.

The long QT interval responsible for torsades de pointes ventricular tachycardia (TdeP VT) can be acquired, congenital or a combination.

Overview of Long QT Syndrome

Pathophysiology of Torsades de Pointes Ventricular Tachycardia

TdeP VT results from any disorder of cardiac ion channel function or regulation that prolongs ventricular myocyte action potential duration as evidenced by prolongation of the rate-corrected QT interval on the ECG (QTc, typically calculated using Bazett's formula). The risk of TdeP VT is dependent on the degree of QTc prolongation, particularly if it is > 0.50 seconds.

TdeP VT may result from

  • Loss of function of repolarizing potassium current channels OR

  • Gain of function of depolarizing sodium or depolarizing calcium current channels

Each of these factors predisposes to TdeP VT by prolonging repolarization, which induces early after-depolarizations (secondary depolarization events during the plateau of the action potential) and spatial dispersion of ventricular refractoriness. The dispersion of refractoriness permits propagation of the early after-depolarizations and initiation of torsade de pointes ventricular tachycardia.

Predisposing factors

The most common factor in acquired TdeP VT is a

Other drugs that can induce TdeP VT include tricyclic antidepressants, phenothiazines, and certain antivirals and antifungals (see CredibleMeds for up-to-date information).

In most cases, there are several predisposing causes, which may include: female sex, older age, hypokalemia Hypokalemia Hypokalemia is serum potassium concentration < 3.5 mEq/L (< 3.5 mmol/L) caused by a deficit in total body potassium stores or abnormal movement of potassium into cells. The most common... read more , hypomagnesemia Hypomagnesemia Hypomagnesemia is serum magnesium concentration < 1.8 mg/dL (< 0.70 mmol/L). Causes include inadequate magnesium intake and absorption or increased excretion due to hypercalcemia or medications... read more , hypothyroidism Hypothyroidism Hypothyroidism is thyroid hormone deficiency. Symptoms include cold intolerance, fatigue, and weight gain. Signs may include a typical facial appearance, hoarse slow speech, and dry skin. Diagnosis... read more Hypothyroidism , slow ventricular rate, irregular ventricular rate, acute intracranial disasters (eg, bleeding, stroke Overview of Stroke Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... read more Overview of Stroke , traumatic brain injury Traumatic Brain Injury (TBI) Traumatic brain injury (TBI) is physical injury to brain tissue that temporarily or permanently impairs brain function. Diagnosis is suspected clinically and confirmed by imaging (primarily... read more Traumatic Brain Injury (TBI) ), eating disorders Introduction to Eating Disorders Eating disorders involve a persistent disturbance of eating or of behavior related to eating that Alters consumption or absorption of food Significantly impairs physical health and/or psychosocial... read more , organophosphate poisoning Organophosphate Poisoning and Carbamate Poisoning Organophosphates and carbamates are common insecticide ingredients that inhibit cholinesterase activity, causing acute muscarinic manifestations (eg, salivation, lacrimation, urination, diarrhea... read more , and structural heart disease (especially acute ischemia, myocarditis, and ventricular hypertrophy).

Symptoms and Signs of Torsades de Pointes Ventricular Tachycardia

TdeP VT often causes syncope because the underlying rate (200 to 250 beats/minute) is nonperfusing. Palpitations are common among conscious patients. Because the QT interval shortens with increased ventricular rates TdeP VT is often self-terminating. However, it instead may degenerate into ventricular fibrillation Ventricular Fibrillation (VF) Ventricular fibrillation causes uncoordinated quivering of the ventricle with no useful contractions. It causes immediate syncope and death within minutes. Treatment is with cardiopulmonary... read more Ventricular Fibrillation (VF) and cause sudden death. Sometimes the long QT interval is detected after resuscitation.

Diagnosis of Torsades de Pointes Ventricular Tachycardia

  • Electrocardiography (ECG)

Diagnosis is by ECG showing an undulating QRS axis, with the polarity of complexes shifting around the baseline (see figure Torsades de pointes ventricular tachycardia Torsades de pointes ventricular tachycardia Torsades de pointes ventricular tachycardia ). ECG between episodes shows a long QT interval after correction for heart rate (QTc). Normal QTc values are about 0.40 second for men and 0.41 second for women and are considered prolonged when > 0.47 second for men or > 0.48 second for women. A family history may suggest a congenital syndrome.

ECG warning signs of impending TdeP VT other than prolongation of the QT interval include

  • T-wave and U-wave fusion (sometimes with giant TU waves)

  • Post-extrasystolic changes in repolarization pattern

  • Macroscopic T-wave alternans (visible alternation of two different appearing T-waves)

  • Frequent polymorphic ventricular premature beats representing single beats of TdeP (often in bigeminy)

  • Repetitive short runs of polymorphic ventricular tachycardia

The TdeP VT itself is a rapid, polymorphic VT that tends to self-terminate. Onset typically follows a short-long-short RR interval initiation sequence (although this sequence is not specific for TdeP VT): The first short RR interval is between a baseline beat (usually a normal beat) and a premature beat (usually a premature ventricular beat). The long RR interval is the post-extrasystolic pause and ends with a baseline beat (usually a normal beat). The pause further prolongs the QT interval of this baseline beat and it is followed by a short RR interval when the TdeP VT begins. Although patients may have a normal QTc at other times, the QTc is usually substantially prolonged around the time of TdeP VT and the QT interval of the last QRS complex prior to TdeP VT must be long (often with a giant TU wave).

Pearls & Pitfalls

  • Torsades de pointe ventricular tachycardia typically follows a short-long-short RR interval initiation sequence and the QT interval of the last QRS complex prior to TdeP VT must be long.

Torsades de pointes ventricular tachycardia

Torsades de pointes ventricular tachycardia

Treatment of Torsades de Pointes Ventricular Tachycardia

  • Unsynchronized direct current cardioversion for ventricular fibrillation

  • Correction of electrolyte abnormalities, especially hypokalemia

  • Magnesium sulfate (MgSO4) IV

  • Treatments to increase basal heart rate, including pacing or IV isoproterenol

  • Treatment of cause

An acute episode prolonged enough to cause hemodynamic compromise is treated with unsynchronized cardioversion Defibrillation Cardiopulmonary resuscitation (CPR) is an organized, sequential response to cardiac arrest, including Recognition of absent breathing and circulation Basic life support with chest compressions... read more , beginning with 100 joules. Nevertheless, early recurrence is the rule. Electrolyte abnormalities (eg, hypokalemia Hypokalemia Hypokalemia is serum potassium concentration < 3.5 mEq/L (< 3.5 mmol/L) caused by a deficit in total body potassium stores or abnormal movement of potassium into cells. The most common... read more ), which can exacerbate the risk of ventricular arrhythmias, should be corrected. Patients often respond to magnesium, usually magnesium sulfate 2 g IV over 1 to 2 minutes. If this treatment is unsuccessful, a 2nd bolus is given in 5 to 10 minutes, and a magnesium infusion of 3 to 20 mg/minute may be started in patients without renal insufficiency. Lidocaine (a class Ib antiarrhythmic drug Class Ib antiarrhythmic drugs The need for treatment of arrhythmias depends on the symptoms and the seriousness of the arrhythmia. Treatment is directed at causes. If necessary, direct antiarrhythmic therapy, including antiarrhythmic... read more ) shortens the QT interval and may be effective especially for drug-induced torsades de pointes. Class Ia, Ic, and III antiarrhythmics are avoided.

If a drug is the cause, it is stopped, but until drug clearance is complete, patients with frequent or long runs of torsades de pointes ventricular tachycardia require treatment to shorten the QT interval. Because increasing the heart rate shortens the QT interval, temporary pacing, IV isoproterenol, or both are often effective. Increasing heart rate will also shorten the “long” in the “short-long-short” initiation sequences of TdeP VT.

Long-term treatment is avoidance of conditions that prolong the QT interval. Some patients with an acquired long QT-interval syndrome have an underlying subclinical congenital long QT-interval syndrome suggested by persistent QTc interval prolongation after removal of exogenous QTc prolonging influences.

Key Points

  • The long QT interval responsible for torsades de pointes ventricular tachycardia can be congenital or acquired.

  • Torsades de pointes runs are usually self-terminating but frequently recurrent.

  • Unsynchronized defibrillation is required if a torsades induces ventricular fibrillation.

  • The torsades rhythm is treated with magnesium sulfate 2 g IV over 1 to 2 minutes, correction of hypokalemia, pacing or isoproterenol to increase heart rate, and correction of the cause.

Drugs Mentioned In This Article

Drug Name Select Trade
7T Lido, Akten , ALOCANE, ANASTIA, AneCream, Anestacon, Aspercreme with Lidocaine, AsperFlex, Astero , BenGay, Blue Tube, Blue-Emu, CidalEaze, DermacinRx Lidocan III, DermacinRx Lidogel, DermacinRx Lidorex, DERMALID, Dologesic, Ela-Max, GEN7T, Glydo, Gold Bond, LidaFlex, LidaMantle, Lido King Maximum Strength, Lidocan, Lidocare, Lidoderm, LidoDose, LidoDose Pediatric, Lidofore, LidoHeal-90, LIDO-K , LidoLite, Lidomar , Lidomark, LidoPure, LidoReal-30, LidoRx, Lidosense 4 , Lidosense 5, Lidosol, Lidosol-50, LIDO-SORB, Lidotral, Lidovix L, LIDOZION, Lidozo, LMX 4, LMX 4 with Tegaderm, LMX 5, LTA, Lubricaine For Her, Lydexa, Moxicaine, Numbonex, ReadySharp Lidocaine, RectaSmoothe, RectiCare, Salonpas Lidocaine, Senatec, Solarcaine, SUN BURNT PLUS, Tranzarel, Xyliderm, Xylocaine, Xylocaine Dental, Xylocaine in Dextrose, Xylocaine MPF, Xylocaine Topical, Xylocaine Topical Jelly, Xylocaine Topical Solution, Xylocaine Viscous, Zilactin-L, Zingo, Zionodi, ZTlido
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!